Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Condition:   HIVInterventions:   Genetic: SB-728-T;   Genetic: SB-728-T;   Genetic: SB-728-T;   Genetic: SB-728-T;   Genetic: SB-728-TSponsor:   Sangamo BiosciencesRecruiting - verified March 2015

Source: ClinicalTrials.gov - March 1, 2012 Category: Research Source Type: clinical trials